Skip navigation

Treatment of neurodegenerative conditions

Treatment of neurodegenerative conditions

BTG International Limited (2005) Treatment of neurodegenerative conditions. WO2005/018632/A1.


Download (3MB)


A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of gamma-linolenic acid, dihomo-gamma-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-beta1 levels in the patient to therapeutic levels.

Item Type: Patent
Additional Information: Publication date: Mar 3, 2005 WO_2005_018632_A1 Application date: Aug 13, 2004 GB_2004003524_W
Uncontrolled Keywords: Treatment of multiple sclerosis
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Education, Health & Human Sciences > Department of Life & Sports Sciences
Related URLs:
Last Modified: 21 Oct 2020 14:37
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
Selected for REF2021: None

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics